p53 mediates nontranscriptional cell death in dopaminergic cells in response to proteasome inhibition (Q28579903)

31 January 2017

title

p53 mediates nontranscriptional cell death in dopaminergic cells in response to proteasome inhibition (English)

1 reference

31 January 2017

1 reference

1 reference

Charles Warren Olanow

5

object named as

C. Warren Olanow

1 reference

31 January 2017

Venugopalan D. Nair

1

1 reference

31 January 2017

Kevin St P. McNaught

2

1 reference

31 January 2017

Javier González-Maeso

3

1 reference

31 January 2017

Stuart C. Sealfon

4

1 reference

31 January 2017

language of work or name

English

0 references

publication date

22 December 2006

1 reference

Journal of Biological Chemistry

31 January 2017

published in

1 reference

31 January 2017

volume

281

1 reference

31 January 2017

issue

51

1 reference

31 January 2017

page(s)

39550–39560

1 reference

Molecular pathophysiology of Parkinson's disease

31 January 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603950200

Failure of the ubiquitin-proteasome system in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603950200

Protein aggregation in the pathogenesis of familial and sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603950200

Altered proteasomal function in sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603950200

Ubiquitination of alpha-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603950200

Selective loss of 20S proteasome alpha-subunits in the substantia nigra pars compacta in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603950200

Proteasomal function is impaired in substantia nigra in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603950200

Brain proteasomal function in sporadic Parkinson's disease and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603950200

Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603950200

Dopaminergic neurons in rat ventral midbrain cultures undergo selective apoptosis and form inclusions, but do not up-regulate iHSP70, following proteasomal inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603950200

Proteasome inhibition and aggregation in Parkinson's disease: a comparative study in untransfected and transfected cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603950200

Proteasomal inhibition leads to formation of ubiquitin/alpha-synuclein-immunoreactive inclusions in PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603950200

Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603950200

Proteasome inhibition causes nigral degeneration with inclusion bodies in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603950200

Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603950200

Reproducible nigral cell loss after systemic proteasomal inhibitor administration to rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603950200

Proteasomal inhibition causes loss of nigral tyrosine hydroxylase neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603950200

Activation of p53 signaling initiates apoptotic death in a cellular model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603950200

Puma and p53 play required roles in death evoked in a cellular model of Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603950200

p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603950200

Transcriptional regulation by p53: one protein, many possibilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603950200

The complexity of p53 stabilization and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603950200

Dissecting p53-dependent apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603950200

p53 has a direct apoptogenic role at the mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603950200

Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603950200

p53 ubiquitination: Mdm2 and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603950200

Early single cell bifurcation of pro- and antiapoptotic states during oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603950200

Activation of phosphoinositide 3-kinase by D2 receptor prevents apoptosis in dopaminergic cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603950200

Agonist-specific transactivation of phosphoinositide 3-kinase signaling pathway mediated by the dopamine D2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603950200

The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603950200

Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603950200

DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603950200

Regulation of p53 stability by Mdm2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603950200

21 January 2018

Surfing the p53 network

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603950200

Regulating the p53 system through ubiquitination

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603950200

Pifithrin-alpha inhibits p53 signaling after interaction of the tumor suppressor protein with hsp90 and its nuclear translocation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603950200

p53 inhibitor pifithrin alpha can suppress heat shock and glucocorticoid signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603950200

Proteasome inhibition and Parkinson's disease modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603950200

Failure of proteasome inhibitor administration to provide a model of Parkinson's disease in rats and monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603950200

Lack of nigrostriatal pathology in a rat model of proteasome inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603950200

Brain-derived growth factor and glial cell line-derived growth factor use distinct intracellular signaling pathways to protect PD cybrids from H2O2-induced neuronal death

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603950200

Staging of brain pathology related to sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603950200

Molecular Pathways of Neurodegeneration in Parkinson's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603950200

Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603950200

21 January 2018

Identifiers

DOI

10.1074/JBC.M603950200

1 reference

31 January 2017

1 reference